ClinicalTrials.gov record
Completed Phase 4 Interventional

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

ClinicalTrials.gov ID: NCT00185120

Public ClinicalTrials.gov record NCT00185120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 12:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study on the Efficacy and Safety of Olmesartan Medoxomil and Its Combination With Hydrochlorothiazide Compared With an ACE Inhibitor and Its Combination With a Calcium Channel Blocker in Patients With Stage 2 Hypertension

Study identification

NCT ID
NCT00185120
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
152 participants

Conditions and interventions

Conditions

Interventions

  • Amlodipine Drug
  • Benazepril Drug
  • Hydroclorothiazide Drug
  • Olmesartan medoxomil Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Aug 31, 2006
Completion
Aug 31, 2006
Last update posted
Jan 17, 2012

2005 – 2006

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Not listed Mobile Alabama 36693
Memorial Research Medical Center Long Beach California 90806
National Research Institute Los Angeles California 90057
Clinical Trials Research Roseville California 95661
Apex Research Institute Santa Ana California 92705
Orange County Research Center Tustin California 92780
Westlake Medical Center Westlake Village California 91361
Clinical Research of South Florida Coral Gables Florida 33134
The Greater Fort Lauderdale Heart Group Research Fort Lauderdale Florida 33308
SFBC International Miami Florida 33142
CLIRECO, Inc. Tamarac Florida 33321
Midwest Institute for Clinical Research Indianapolis Indiana 46260
Heartland Research Associates Wichita Kansas 67207
Androscoggin Cardiology Research Auburn Maine 04210
Internal Medicine Associates of Charlotte Charlotte North Carolina 28211
Piedmont Medical Research Associates Winston-Salem North Carolina 27103
The Lindner Clinical Trial Center Cincinnati Ohio 45319
Omega Medical Research Warwick Rhode Island 02886
Volunteer Research Group, University of Tennessee Med. Ctr. Knoxville Tennessee 37920
Punzi Medical Center Carrollton Texas 75006

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00185120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2012 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00185120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →